Chengdu Rongchuang Xiandao Equity Investment Fund was registered and established with a capital contribution of 2 billion yuan.

According to US Stock Research Society, Tianyancha App shows that recently, Chengdu Rongchuang XianDao Equity Investment Fund Partnership (Limited Partnership) was established, with Chengdu Jizhuan Venture Capital Co., Ltd. as the executive partner, with a capital contribution of 2 billion RMB. The business scope includes engaging in equity investment, investment management, and asset management activities through private funds. Partner information shows that the fund is jointly funded by Chengdu XianDao Pharmaceutical Development Co., Ltd., Chengdu Wutongshu Innovation and Entrepreneurship Investment Partnership (Limited Partnership), Chengdu Gaoxin Ceyuan Qihang Equity Investment Fund Partnership (Limited Partnership), etc. According to media reports, the signing ceremony of Chengdu Rongchuang XianDao Equity Investment Fund was recently held in Chengdu High-tech Zone. The establishment of the fund aims to further promote the "building circles and strengthening chains" of Chengdu's biopharmaceutical industry, accelerate the cultivation of "chain leader" enterprises, and speed up the formation of a biopharmaceutical industry pattern with "leading geese and chain leaders driving," thereby promoting the accelerated development of Chengdu's biopharmaceutical industry.